CMS published a final rule updating oversight of Organ Procurement Organizations, including a definition of 'unsound medical practices,' clearer decertification pathways, and stronger enforcement tools. The rule is aimed at improving patient protections and the safety and integrity of the transplant system. By clarifying when CMS can act against OPO performance and practices, the regulation strengthens federal accountability in a high-stakes area of healthcare administration.
